- Home
- HUT vs QGEN Comparison
HUT vs QGEN Comparison
Compare HUT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUT | QGEN |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 9.0B |
| IPO Year | 2023 | 1998 |
Fundamental Metrics
Financial Performance| Metric | HUT | QGEN |
|---|---|---|
| Price | $61.43 | $50.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 16 |
| Target Price | ★ $152.78 | $48.13 |
| AVG Volume (30 Days) | ★ 5.2M | 4.2M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 5.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $235,118,000.00 | N/A |
| Revenue This Year | $25.69 | $2.16 |
| Revenue Next Year | $94.23 | $5.06 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | ★ 44.79 | N/A |
| 52 Week Low | $31.67 | $32.53 |
| 52 Week High | $140.80 | $57.82 |
Technical Indicators
Market Signals| Indicator | HUT | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 30.39 | 74.21 |
| Support Level | $44.69 | $49.37 |
| Resistance Level | $61.59 | $52.20 |
| Average True Range (ATR) | 6.58 | 1.34 |
| MACD | -2.07 | 0.52 |
| Stochastic Oscillator | 0.02 | 94.14 |
Price Performance
Historical ComparisonAbout HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).